Dare Bioscience, Inc. Public Float
Dare Bioscience, Inc. (DARE) had Public Float of $21.34 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $21.34M.
- 2024-06-30: Entity Public Float $33.97M.
- 2023-06-30: Entity Public Float $77.32M.
- 2022-06-30: Entity Public Float $102.28M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $21.34M 10-K · filed 2026-03-26 |
| 2024-06-30 | $33.97M 10-K · filed 2025-03-31 |
| 2023-06-30 | $77.32M 10-K · filed 2024-03-28 |
| 2022-06-30 | $102.28M 10-K · filed 2023-03-30 |
| 2021-06-30 | $85.85M 10-K · filed 2022-03-31 |
| 2020-06-30 | $22.80M 10-K · filed 2021-03-30 |
| 2019-06-28 | $12.23M 10-K · filed 2020-03-27 |
| 2018-06-30 | $10.68M 10-K · filed 2019-04-01 |
| 2017-06-30 | $52.14M 10-K · filed 2018-03-28 |
| 2016-06-30 | $47.57M 10-K/A · filed 2017-06-13 |
| 2015-06-30 | $92.19M 10-K · filed 2016-03-10 |
| 2014-06-30 | $74.21M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |